Coin Market Solution logo Coin Market Solution logo
amzn_assoc_placement = "adunit0"; amzn_assoc_search_bar = "true"; amzn_assoc_tracking_id = "zoneclassifie-20"; amzn_assoc_ad_mode = "manual"; amzn_assoc_ad_type = "smart"; amzn_assoc_marketplace = "amazon"; amzn_assoc_region = "US"; amzn_assoc_title = "Zone Amazon Picks"; amzn_assoc_linkid = "d3f6b917bd73580d5f8c38b01615c334"; amzn_assoc_asins = "B07L4ZW3T8,B09CYMV75Y,B00004SWL0,B08F9JN2BK";
Cryptopolitan 2021-09-26 03:00:00

Patientory and its Role in Clinical Trials Transparency

According to a recent study, only 29% of trial results make it into journals. Only 13% of these results are reported on the ClinicalTrials.gov page two years after completing the clinical trial. The problem of trial results accessibility and transparency goes back ages. Benefits of clinical trials transparency  Timely disclosure of clinical trial results offers numerous advantages. Patients suffering from life-threatening conditions can willingly enroll in the trial if they have access to past trial results, especially when they are positive.  Trial results can serve as CME (Continuing Medical Education) to physicians and help improve medical consultation services. The shortcomings of prior research can help scientists design better protocols. Based on trial results, the participants can make the right healthcare decisions.  Challenges of clinical trials transparency  Regulatory authorities like the FDA, WHO and Bioethics International have established rules to ensure that sponsors disclose accurate results of trials soon after completion.  However, stringent compliance rules of disclosure make it a daunting task. In this regard, challenges to accurate reporting of results are: The absence of a single-source integrated system that can be updated from anywhere in the worldMaintenance of the integrity of trial recruitment by providing limited accessUser-friendly dashboards that are easy to readAbility t...

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.